Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Opioid Consumption, Postoperative × Dexmedetomidine × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pain, Postoperative 19 Breast Neoplasms 13 Brain Neoplasms 11 Agnosia 7 Neoplasms 6 Lung Neoplasms 5 Delirium 5 Thyroid Neoplasms 4 Stomach Neoplasms 4 Pituitary Neoplasms 3 Pain 3 Inflammation 3 Emergence Delirium 3 Colorectal Neoplasms 3 Chronic Pain 3 Urinary Bladder Neoplasms 2 Supratentorial Neoplasms 2 Rectal Neoplasms 2 Prostatic Neoplasms 2 Pheochromocytoma 2 Pain, Intractable 2 Neoplasm Metastasis 2 Liver Neoplasms 2 Dexmedetomidine 2 Colonic Neoplasms 2 Central Nervous System Diseases 2 Abdominal Neoplasms 2 Thrombosis 1 Spinal Cord Neoplasms 1 Sleep Initiation and Maintenance Disorders 1

Interventions

Dexmedetomidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07263165 2025-12-04

Dexmedetomidin

Assiut University

Phase NA Not yet recruiting

Opioid Consumption, Postoperative

Data powered by HemOnc (CC BY 4.0) Colophon ⚡